Skip to main content

How do you perform a monthly review that improves your investing?

Daily routines keep you informed. Weekly deep dives build expertise. A monthly review is where you zoom out and assess whether your strategy is working. Most investors are trapped in a short-term cycle: they read news, react to moves, and check their portfolios obsessively, but they never step back to ask bigger questions. Is my portfolio performing as I expected? Are my thesis holding true? Have market conditions changed enough to warrant a strategic shift? Have I learned anything that should change my approach? A monthly review answers these questions and prevents you from being blindsided by slow trends or gradual strategy drift.

Quick definition: A monthly review routine is a structured, monthly assessment of your portfolio's performance, the macroeconomic and market environment, your investment thesis, and any needed adjustments to your strategy or positions.

Key takeaways​

  • Monthly reviews create discipline and prevent you from being reactive to daily noise.
  • A full monthly review takes 2–3 hours and should cover four components: portfolio performance, macroeconomic trends, personal thesis validation, and strategic adjustments.
  • Compare your portfolio to benchmarks (not just absolute returns) to isolate whether outperformance came from skill or market conditions.
  • Use monthly reviews to identify and question consensus narratives that might be embedded in your positions.
  • Document your review in writing so you can look back and assess your own decision-making.

Why monthly reviews matter​

The human brain is wired for patterns, but we often see patterns that don't exist or miss patterns hiding in plain sight. Reading news and making trades creates a feeling of control. But that feeling can be deceptive. You might feel like you're winning because the market is up 5%, but you're underperforming the index. Or you might feel like a position is working because the stock is up, but it's up because the entire sector is up, not because of your specific thesis.

A monthly review forces you to look at data, not feelings. It answers questions like: Is my portfolio beating or underperforming? Did I make good trades, or did I get lucky? Are the things I said would happen actually happening? Are there macro trends I've missed?

Consider a concrete example: In early 2021, many investors were bullish on tech stocks and pandemic winners (companies that benefited from remote work and e-commerce). Month after month, they felt smart: the tech-heavy Nasdaq was up 20%, 30%, 40%. But if they had done a monthly review comparing their portfolio to the S&P 500, they would have noticed they were matching the index, not outperforming. They had no edge; they were just riding the market. Then in 2022, when the market rotated away from growth stocks, their portfolios collapsed, and they felt blindsided. A monthly review during the good times would have revealed the lack of edge and prevented the overconfidence.

Conversely, a monthly review can validate a thesis that's working. If you deliberately underweighted tech in 2022 because you believed growth stocks would underperform, a monthly review would have shown your conviction was working. Seeing that data would have given you confidence to hold or even add during the painful drawdown in 2022.

Component 1: Assess portfolio performance​

The first component of your monthly review is a brutal assessment of how your portfolio performed.

Measure absolute returns. What did your portfolio return this month? If you own stocks, you can calculate this easily: (Ending Value - Beginning Value - Contributions) / Beginning Value = Return. If you had a $100,000 portfolio at the start of the month and added $5,000, and it's worth $107,500 at month-end, your return is: ($107,500 - $100,000 - $5,000) / $100,000 = 2.5%.

Benchmark against an appropriate index. Did the S&P 500 return 2%, 3%, or 5% this month? How did your return compare? If the S&P 500 returned 2.5% and your portfolio returned 2.5%, you matched the market. This is meaningful context: it tells you your stock-picking (or sector allocation) added zero value this month.

The appropriate benchmark depends on your portfolio. If you own mostly U.S. large-cap stocks, the S&P 500 is the right benchmark. If you own international stocks, the MSCI All-Country World Index is better. If you own bonds, the Bloomberg Aggregate Bond Index is the benchmark. Using the wrong benchmark is a common mistake: comparing your all-stocks portfolio to a 60/40 stock/bond benchmark makes you look better than you are because stocks outperformed bonds.

Identify which holdings drove performance. Which of your positions were the biggest winners? Which were losers? Did your outperformance come from a few big winners or broad-based strength? Concentration matters. If 80% of your outperformance came from one position, you might not have an edge; you might have gotten lucky on one bet.

Assess your worst-performing positions separately. The positions that lagged the market deserve scrutiny. Is the underperformance temporary (sector weakness, bad earnings) or a sign your thesis is broken? Is the company fundamentally weaker, or are you just experiencing normal volatility? This is where you decide whether to hold, add, or sell.

Document this for the month. Write it down: "Portfolio returned 1.5%, underperforming S&P 500 (2.0%) by -0.5%. Underperformance due to underweight in Magnificent Seven tech stocks. Healthcare holdings outperformed sector on strong earnings." This memo is for your learning. In six months or a year, you'll reread it and assess whether the underperformance was justified or a mistake.

Component 2: Review the macroeconomic environment​

Your portfolio operates in a macroeconomic context. Inflation, interest rates, employment, and growth outlook shape returns. A monthly review includes a brief assessment of how the macro environment has shifted.

Review the month's key economic releases. The Bureau of Labor Statistics releases employment data monthly. The Federal Reserve provides inflation (CPI/PCE) and other indicators. Check whether the month's data came in stronger or weaker than expected. Did unemployment rise or fall? Did inflation accelerate or decelerate? Did GDP growth accelerate?

Note any shift in Fed policy expectations. Central banks' policy decisions have outsized impacts on markets. If the Fed raised interest rates, how did markets react? Did the rate rise suggest more hikes coming, or is the Fed near the end of its tightening cycle? Changes in rate expectations reshape valuations quickly.

Assess whether the macro backdrop is improving or deteriorating. Is the economy accelerating, slowing, or stable? Is inflation a growing concern, or is it controlled? Are employment levels robust or softening? A monthly assessment of the macro trend helps you understand whether your portfolio positioning makes sense.

Compare your macro view to market pricing. The market prices in expectations about future economic conditions. If you expect a recession but the market is pricing in soft landing (slower growth but no recession), that's a material disagreement. A monthly review makes this disagreement explicit and forces you to ask: Am I seeing something the market is missing, or am I overconfident in my view?

Document this too: "Macro environment softened this month. Unemployment rose to 4.2% (vs 3.8% last month). CPI moderated to 3.0% (vs 3.2% last month). Fed is likely on pause, with markets pricing in rate cuts in 2024. Economic backdrop suggests slower growth is coming, which supports our underweight in cyclicals and overweight in defensive sectors." This clarity prevents you from drifting into positions that don't match your macro view.

Component 3: Test your investment thesis​

You hold each position in your portfolio because you have a thesis: a reason you believe the position will outperform. A monthly review is where you test whether the thesis is still holding.

For each significant position, ask:

Is the thesis coming true? If you own a stock because you believe its AI business will accelerate, is AI business accelerating? If earnings reports show AI revenue flat or declining, your thesis is being disproven. This doesn't always mean you should sell—sometimes plays take longer than expected—but it means you should consciously reaffirm the thesis or adjust it.

Have the facts changed? Sometimes external facts change, not the company's performance. If you underweighted tech stocks because you thought valuations were high and interest rates would rise, and interest rates have fallen sharply, your original thesis is less relevant. This warrants adjusting your position.

Are you rationalizing a losing position? This is the hardest question. If a position is down 30% since you bought it, is it a long-term conviction that's just undervalued (in which case you hold), or is it a mistake (in which case you consider selling)? Look for signs you're rationalizing: "Well, the market is wrong, and it will realize this is a great company eventually." If you're constantly updating the thesis to match new facts, you're probably rationalizing.

A useful exercise is to write down your original thesis when you bought a position. Then monthly, reread it and ask: "Is what I said would happen actually happening?" If the answer is consistently no, it's time to sell and redeploy capital elsewhere.

Example thesis documentation:

"Position: Nvidia, 8% of portfolio

Original Thesis (May 2023): AI adoption will drive sustained demand for GPU chips for data center training and inference. Nvidia has 90%+ market share. Even if growth moderates from 200% to 50% annually, the business will be highly profitable. Valuation of 60x earnings is expensive, but growth justifies it.

Current Status (June 2023): Thesis still holding. Q1 results beat expectations, and management remains confident in demand. Valuation compressed to 50x on broader market weakness, improving risk/reward.

October 2023: Thesis showing signs of stress. Q2 guidance was conservative; management cited customer inventory builds. Valuation remains at 50x despite lower growth expectations. Need to reassess whether 50x is justified for 30–50% growth vs 100%+ growth."

Component 4: Strategic adjustments​

After reviewing performance, macro, and your thesis, the final component is deciding whether to adjust your strategy or positions.

Rebalancing. If your portfolio targets 70% stocks and 30% bonds, but market moves have pushed it to 75% stocks and 25% bonds, a monthly review is a good time to rebalance. Rebalancing forces you to sell winners and buy losers, which is emotionally hard but mathematically sound. Don't rebalance monthly if you're a long-term buy-and-hold investor; rebalance quarterly or annually instead. But if you're active, monthly rebalancing is reasonable.

Adding to winners. If a thesis is working and the position is underweight, you might add to it. However, avoid the trap of chasing momentum. Add only if you're more confident in the thesis, not just because the stock has gone up.

Trimming or selling losers. If a thesis is broken or a position has become too concentrated, you might trim. Be careful here too: most investors trim winners to lock in gains and hold losers, which is backward. Trim positions where the thesis is broken or where concentration has gotten too high. Hold positions where the thesis is still working.

Sector or geopolitical allocation shifts. If your monthly review suggests a change in macro outlook, you might adjust your sector allocation or international/U.S. allocation. If you were bullish on cyclicals (materials, energy) but now believe growth is slowing, you might rotate toward defensives (utilities, staples).

Educational gaps. If your monthly review surfaced a topic you don't understand (e.g., Fed policy, supply chains, geopolitics), schedule deep research on that topic. Your future monthly reviews will be better because you'll understand the context.

Document these adjustments: "No rebalancing needed; portfolio is on target. Added $10,000 to Nvidia after reading latest earnings transcript; AI thesis is accelerating faster than expected. Reduced energy sector exposure from 5% to 3% due to concerns about crude oil prices normalizing as production increases. Scheduled deep dive on semiconductor industry for next week."

Real-world example: A full monthly review​

Let's walk through a complete monthly review for an investor with a diversified portfolio.

Sunday, 2 p.m. You block out three hours for your monthly review. You open a spreadsheet with your portfolio:

  • 40% S&P 500 index fund
  • 15% Nvidia (individual stock)
  • 15% Healthcare sector ETF
  • 10% International developed markets
  • 10% Emerging markets
  • 10% Bonds

Step 1: Calculate performance (30 min). Your portfolio started the month at $500,000. You added $2,000 in contributions. Ending value is $515,000. Your return: ($515,000 - $500,000 - $2,000) / $500,000 = 2.6%.

S&P 500 returned 3.2% this month. You underperformed by 0.6%. You investigate why:

  • Your S&P 500 index fund returned 3.2%, matching the index. Good.
  • Your Nvidia position returned 5.0%, outperforming the index. Great.
  • Your healthcare ETF returned 2.1%, underperforming the index. The healthcare sector had a weak month.
  • Your international and emerging market positions returned 1.5% and 0.5%, respectively. International markets underperformed U.S. markets.
  • Your bonds returned 0.8%.

Overall, your underperformance came from the overweight in international markets and underweight in U.S. large-cap (beyond your index fund). Your best position (Nvidia) is helping, but it's not enough to offset international weakness.

Step 2: Review macroeconomic environment (30 min). You review the month's economic releases. Unemployment ticked up to 4.2% from 4.0%. CPI came in at 3.2%, down from 3.4%. The Fed held rates steady and signaled a pause in tightening. Bond yields fell 25 basis points, suggesting market now expects rate cuts next year.

You note: "Macro backdrop shifted toward lower rates and slower growth expectations. This supports international markets and bonds (which rally when growth slows), but hasn't materialized yet. International markets are still weak. The lag suggests markets don't yet believe in the slowdown narrative."

Step 3: Test your theses (60 min).

"Position: Nvidia (15% of portfolio, up 5% this month)

Original thesis: AI will drive GPUs demand for years. Nvidia has 90%+ market share. Valuation of 60x earnings is justified.

Current facts: Nvidia beat earnings. Guidance was conservative due to customer inventory. Valuation compressed to 50x. AI adoption seems to be accelerating based on announcements from major cloud providers.

Assessment: Thesis still holding. The conservative guidance is actually reassuring (management isn't hype-driven). I should consider this a buying opportunity as sentiment cools on growth concerns."

"Position: Healthcare ETF (15% of portfolio, down 1.1% relative to market)

Original thesis: Healthcare is defensive. Demographics (aging population) support long-term growth. Valuations are reasonable at 16x earnings.

Current facts: Healthcare underperformed this month. CPI moderation supports technology over healthcare (investors rotating to growth). Healthcare valuations remain at 16x.

Assessment: Thesis is long-term, and monthly underperformance doesn't change it. Hold. The rotation from healthcare to growth is temporary sentiment, not fundamental."

"Position: International developed markets (10% of portfolio, down 1.7% relative to U.S.)

Original thesis: International markets are cheaper than U.S. markets (14x earnings vs 20x). Currency diversification is good. Europe's economic outlook is improving.

Current facts: International markets continue to underperform despite valuation advantage. Europe's economic data is mixed. U.S. is outperforming due to mega-cap AI enthusiasm.

Assessment: Thesis is being tested. I said Europe's outlook is improving, but data isn't confirming it. I should either reduce exposure (acknowledge thesis is wrong) or double down (acknowledge I'm early and markets will eventually recognize value). Decision: Reduce from 10% to 8% to derisk. Will reassess in two months if economic data doesn't improve."

Step 4: Strategic adjustments (20 min).

Based on your review:

  • No rebalancing needed; portfolio is on target.
  • Reduce international developed markets from 10% to 8%, trimming $10,000. Redeploy to bonds (now more attractive with lower yields and lower growth expectations).
  • Keep Nvidia as-is; might add if next month's earnings are strong.
  • Healthcare: hold, no changes.

You document this: "Monthly review of [Month], [Year]. Portfolio returned 2.6%, underperforming S&P 500 by 0.6%. Underperformance due to international weakness despite valuation advantage. Macro backdrop shifted toward lower growth and lower rates. Made one adjustment: trimmed international developed markets to 8% to reduce tracking error vs. U.S.-focused investors. Thesis on Nvidia validated by strong earnings and conservative guidance. Will monitor international markets for reversal or confirm thesis is broken."

Step 5: Plan for next month (10 min).

What will you watch next month?

  • European economic data: If continues to disappoint, abandon international thesis entirely.
  • Nvidia earnings: If beats again, consider adding.
  • Bond market: If yields stay low, consider adding more bonds.
  • Fed communications: If Fed signals rate cuts, that's bullish for growth (contrary to recent narrative).

You close your review feeling more informed and deliberate. You've identified that your international exposure is a dragging thesis and made a data-driven decision to reduce it. You've confirmed your Nvidia conviction is still valid. You understand the macro backdrop is shifting toward lower rates and slower growth, which affects your outlook. You're ready for the next month.

How to find time for a monthly review​

A monthly review takes 2–3 hours. Unlike weekly deep dives, this can't happen during a lunch break. It deserves dedicated time.

  • End of month weekend. Many investors do their monthly review on the last Saturday or Sunday of the month. It's a natural checkpoint and gives you all of the month's data.
  • First day of the new month. Some investors prefer to review the previous month on the first day of the new month. This ensures you're not racing against a deadline.
  • Quarterly instead of monthly. If monthly feels like too much, quarterly (every three months) is reasonable. Most professional investors do quarterly reviews at minimum.

The key is consistency. Make it a calendar event and protect the time.

Common mistakes in monthly reviews​

Mistake 1: Confusing coincidence with causation. "My portfolio underperformed because I own too many tech stocks." But maybe underperformance is due to one bad trade, not sector allocation. Look deeper.

Mistake 2: Obsessing over tiny performance differences. If your portfolio returned 2.3% and the benchmark returned 2.5%, the 0.2% difference is likely noise, not evidence you need to restructure. Focus on meaningful misses (1%+).

Mistake 3: Rationalizing bad decisions instead of learning from them. If you made a trade that lost money, the goal of the review is to learn why it was a mistake, not to convince yourself it wasn't actually a mistake.

Mistake 4: Changing strategy every month. Some investors use monthly reviews to justify constant repositioning. If you're adjusting your allocation every month, you don't have a strategy; you have a trading plan. Be slower to change.

Mistake 5: Ignoring underperformance because you're "long-term." Long-term investing doesn't mean ignoring problems. If your thesis is broken, you should acknowledge it and decide whether to hold (because you believe the thesis will eventually work) or sell (because the thesis is wrong). Not deciding is just inertia.

FAQ​

Should I do a monthly review if my portfolio is index-based and I don't trade?​

Yes. Even if you're buy-and-hold, a monthly review helps you understand whether the macro environment is changing your outlook and whether you need to rebalance. You don't need to make changes, but you should be aware of what's happening. The SEC's Edgar database and Federal Reserve publications provide public data to inform your understanding.

What's the difference between a monthly review and a quarterly review?​

Quarterly is sufficient for long-term investors; monthly is better for active investors. Quarterly is 15 data points per year (more statistically reliable than monthly's 12). Monthly is more current but creates more noise. Choose based on your investing style.

Should I review individual stocks separately from my portfolio return?​

Yes. A stock might be up 10%, but if the index is up 15%, the stock underperformed. Reviewing stocks in isolation can be misleading.

What if I can't calculate my exact return because I add money at different times?​

Use time-weighted return if you're tracking performance carefully, or just track beginning-to-end value and account for contributions. Perfect precision isn't necessary for a monthly review; the goal is direction and magnitude, not exact figures.

How long should my monthly review memo be?​

One to two pages. Short enough that you can reread it later without effort, long enough to capture the key insights. If it's under half a page, you probably didn't think deeply enough. If it's more than three pages, you're over-analyzing.

Should I share my monthly review with anyone?​

Not necessarily. It's for you. But some investors find it helpful to discuss their review with a trusted friend or financial advisor. An outside perspective can catch blind spots.

Summary​

A monthly review is where you zoom out from daily chaos and assess whether your investment strategy is working. Divide your review into four components: measure your portfolio's absolute return and compare it to a benchmark, assess the month's macroeconomic changes and implications, test whether your investment theses are still holding, and decide whether any strategic adjustments are warranted. Document your review in writing so you can look back and assess your own decision-making. Monthly reviews create discipline, prevent blindsided surprises, and build your awareness of what's working and what's not. Over time, this practice turns investing from reactive news-reading into deliberate strategy execution.

Next​

→ News tools and aggregators